Tag: ivonescimab

Clinical Trials & Research

Ivonescimab Scores Landmark Phase III Win in Biliary Tract Cancer, Solidifying Summit and Akeso’s High-Stakes Bet

Executive Overview The landscape of modern immuno-oncology is shifting once again, driven by a novel class of bispecific antibodies designed...

26 Aug 2026

Clinical Trials & Research

Akeso Doses First Patient in Landmark Phase II Trial Evaluating Novel AK146D1 and Ivonescimab Combination for Advanced Breast Cancer

Executive Overview In a significant milestone for next-generation oncology drug development, biopharmaceutical innovator Akeso has announced the successful dosing of...

10 Aug 2026

Clinical Trials & Research

Summit Therapeutics Expands Global Oncology Footprint with Phase II/III HARMONi-GU1 Trial of Ivonescimab in Advanced Urothelial Carcinoma

Executive Overview In a significant strategic expansion of its oncology clinical development pipeline, Summit Therapeutics has announced the initiation of...

8 Aug 2026